Neuberger Berman Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,608	Closed	-$236K	–	2037
2024 Q4	$236K	Sell	5,608 -6	-0.1%	-$298	﹤0.01%	1744
2024 Q3	$312K	Buy	+5,614	New	+$286K	﹤0.01%	1672
2024 Q2	–	Sell	-104,939	Closed	-$4.9M	–	1957
2024 Q1	$4.9M	Buy	104,939 +35,193	+50%	+$1.66M	﹤0.01%	931
2023 Q4	$3.34M	Sell	69,746 -63,240	-48%	-$2.45M	﹤0.01%	1003
2023 Q3	$4.74M	Buy	132,986 +30,341	+30%	+$1.2M	﹤0.01%	890
2023 Q2	$4.74M	Buy	102,645 +33,969	+49%	+$1.58M	﹤0.01%	902
2023 Q1	$2.75M	Buy	68,676 +28,890	+73%	+$1.24M	﹤0.01%	1003
2022 Q4	$1.84M	Buy	+39,786	New	+$1.56M	﹤0.01%	1087
2021 Q2	–	Sell	-18,585	Closed	-$2.12M	–	1826
2021 Q1	$2.12M	Sell	18,585 -6,042	-25%	-$823K	﹤0.01%	1138
2020 Q4	$3.41M	Sell	24,627 -2,373	-9%	-$282K	﹤0.01%	1005
2020 Q3	$2.22M	Buy	27,000 +7,000	+35%	+$580K	﹤0.01%	1045
2020 Q2	$1.56M	Sell	20,000 -2,000	-9%	-$132K	﹤0.01%	1060
2020 Q1	$977K	Buy	+22,000	New	+$1.14M	﹤0.01%	1101